About this trial
The ClotPro analyzer is a new generation viscoelastic analyzer for the in vitro assessment of blood coagulation. This study aims to assess the agreement of ClotPro 6.0, ROTEM delta, and TEG 6s in three distinct cohorts: i) patients with liver disease undergoing liver surgery, ii) pregnant women undergoing elective cesarean section, and iii) patients undergoing elective intracranial neurosurgery. Further coagulation tests will be performed (standard laboratory coagulation tests, thrombin and plasmin generation tests) in an exploratory fashion to compare them with viscoelastic test results. The obtained test results will not result in any diagnostic or therapeutic consequences for patients included in this study.
Eligibility criteria
Qualifiers
Vulnerable patient cohorts
Liver resection (anatomic or non-anatomic segmental resection, right or left hepatectomy, right or left extended hepatectomy),
Orthotopic liver transplantation,
Pregnant women undergoing an elective caesarean section, and
Disqualifiers
None
Trial design
Treatments tested in this trial
- Viscoelastic testing
Treatment groups
Sponsors and collaborators
Medical University of Vienna
Lead sponsor
Synapse - Research Institute Maastricht
Collaborator